Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun;143(6):696-711.
doi: 10.4103/0971-5916.191927.

Strategies & recent development of transmission-blocking vaccines against Plasmodium falciparum

Neha Chaturvedi  1 , Praveen K Bharti  2 , Archana Tiwari  3 , Neeru Singh  2
Affiliations
Review

Strategies & recent development of transmission-blocking vaccines against Plasmodium falciparum

Neha Chaturvedi et al. Indian J Med Res. 2016 Jun.

Abstract

Transmission blocking malaria vaccines are aimed to block the development and maturity of sexual stages of parasite within mosquitoes. The vaccine candidate antigens (Pfs25, Pfs48/45, Pfs230) that have shown transmission blocking immunity in model systems are in different stages of development. These antigens are immunogenic with limited genetic diversity. Pfs25 is a leading candidate and currently in phase I clinical trial. Efforts are now focused on the cost-effective production of potent antigens using safe adjuvants and optimization of vaccine delivery system that are capable of inducing strong immune responses. This review addresses the potential usefulness, development strategies, challenges, clinical trials and current status of Plasmodium falciparum sexual stage malaria vaccine candidate antigens for the development of transmission-blocking vaccines.

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. World Malaria Report 2015. Geneva: World Health Organization. 2015. [accessed on April 1, 2014]. Available from: http://www.who.int/malaria/publications/world-malaria-report-2015/report...
    1. World Malaria Report 2010. Geneva: World Health Organization. 2010. [accessed on April 1, 2014]. Available from: http://www.who.int/malaria/world_malaria_report_2010/en/
    1. Carter R, Mendis KN, Miller L, Saul A. Malaria transmission-blocking vaccine-how can their development be supported? Nature Med. 2000;6:241–4. - PubMed
    1. Sauerwein RW, Eling WM. Sexual and sporogonic stage antigens. Chem Immunol. 2002;80:188–203. - PubMed
    1. Templeton TJ, Kaslow DC. Identification of additional members defines a Plasmodium falciparum gene superfamily which includes Pfs48/45 and Pfs230. Mol Biochem Parasitol. 1999;101:223–7. - PubMed

MeSH terms